Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase I/IIa Trial Evaluating scAAV1.tMCK.NTF3 for Treatment of Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A)

This clinical trial is an open-label one-time injection dose study in which scAAV1.tMCK.NTF3 will be administered by intramuscular injections into muscles in b…

Charcot-Marie-Tooth Neuropathy Type 1A

Nationwide Children's HospitalNCT03520751